Mbrace Therapeutics
Clinical trials sponsored by Mbrace Therapeutics, explained in plain language.
-
New drug targets tough cancers in early trial
Disease control Recruiting nowThis study tests a new drug, MBRC-101, in people with advanced solid tumors that have stopped responding to standard treatments. The drug is designed to deliver a chemotherapy-like agent directly to cancer cells. The trial aims to find the safest and most effective dose, and to s…
Phase: PHASE1, PHASE2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:05 UTC
-
New Antibody-Drug conjugate targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called MBRC-201 in people with advanced solid tumors (like prostate, breast, lung, colorectal, or pancreatic cancer) that have not responded to standard therapies. The drug is an antibody-drug conjugate, designed to deliver a cancer-killing agent direc…
Phase: PHASE1, PHASE2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated May 26, 2026 03:59 UTC